Perforin: An important player in immune response

Central European Journal of Immunology

Volumn 39, Issue 1, 2014, Pages 109-115

  Osińska, Iwona ^a   Popko, Katarzyna ^a   Demkow, Urszula ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Autoimmune diseases; Cytolytic granules; Granzyme; Hashimoto's disease; HLH; SLE; Type 1 diabetes

Indexed keywords

PERFORIN;

AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNE RESPONSE; INFECTION; LEUKEMIA; LYMPHOMA; NATURAL KILLER CELL; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW;

EID: 84900552329     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2014.42135     Document Type: Review

References (28)

1. Lichtenheld MG, Olsen KJ, Lu P, et al. (1988): Structure and function of human perforin. Nature 335: 448-451.
2. Law RH, Lukoyanova N, Voskoboinik I, et al. (2010): The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 468: 447-451.
3. Voskoboinik I, Dunstone MA, Baran K, et al. (2010): Perforin: structure, function, and role in human immunopathology. Immunol Rev 235: 35-54.
4. Williams NS, Engelhard VH (1997): Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells. J Immunol 159: 2091-2099. (Pubitemid 127680996)
5. van den Broek MF, Hengartner H (2000): The role of perforin in infections and tumour surveillance. Exp Physiol 85: 681-685.
6. Trapani JA, Smyth MJ (2002): Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2: 735-747. (Pubitemid 37328714)
7. Young JD, Liu CC, Persechini PM (1988): Molecular mechanisms of lymphocyte-mediated killing. Braz J Med Biol Res 21: 1145-1153.
8. Lasek W, Malejczyk J (2007): Mechanizmy cytotoksyczności limfocytów. In: Immunologia. Goła̧b J, Jakóbisiak M, Lasek W, Stokłosa T (eds.). PWN, Warszawa; 241-249.
9. Liu CC1, Young LH, Young JD (1996): Lymphocyte-mediated cytolysis and disease. N Engl J Med 335: 1651-1659.
10. 2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules. Biochemistry 37: 10386-10394.
11. Morgan BP, Harris CL (1999): Regulation in the terminal pathway. In: Complement regulatory proteins. Academic Press, Cambridge; 143.
12. Tschopp J, Masson D, Schäfer S, et al. (1988): The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities. Biochemistry 27: 4103-4109.
13. Voskoboinik I, Smyth MJ, Trapani JA (2006): Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 6: 940-952. (Pubitemid 44851736)
14. Jiang SB, Ojcius DM, Young JD (1990): Perforin binding to cells and lipid membranes determined by a simple competition assay. J Immunol Methods 126: 29-37. (Pubitemid 20041424)
15. Liu CC, Jiang S, Persechini PM, et al. (1989): Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity. J Exp Med 169: 2211-2225. (Pubitemid 19162978)
16. Zuber B, Levitsky V, Jönsson G, et al. (2005): Detection of human perforin by ELISpot and ELISA: ex vivo identification of virus-specific cells. J Immunol Methods 302: 13-25. (Pubitemid 41111869)
17. Lehmann C, Zeis M, Schmitz N, Uharek L (2000): Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells. Blood 96: 594-600. (Pubitemid 30463380)
18. Jȩdrzejczak WW (2008): Limfohistocytoza hemofagocytarna - rzadko rozpoznawany uleczalny stan bezpośredniego zagrożenia życia wystȩpuja̧cy również u dorosłych. Acta Heamato Pol 39: 515-526.
19. Kogawa K, Lee SM, Villanueva J, et al. (2002): Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 99: 61-66.
20. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. (1999): Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286: 1957-1959. (Pubitemid 129515904)
21. Katano H, Ali MA, Patera AC, et al. (2004): Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood 103: 1244-1252. (Pubitemid 38168634)
22. Kägi D, Ledermann B, Bürki K, et al. (1994): Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369: 31-37. (Pubitemid 24144352)
23. van den Broek ME, Kägi D, Ossendorp F, et al. (1996): Decreased tumor surveillance in perforin-deficient mice. J Exp Med 184: 1781-1790. (Pubitemid 26404469)
24. Rousalova I, Krepela E (2010): Granzyme B-induced apoptosis in cancer cells and its regulation. Int J Oncol 37: 1361-1378.
25. Gupta M, Greer P, Mahanty S, et al. (2005): CD8-mediated protection against Ebola virus infection is perforin dependent. J Immunol 174: 4198-4202. (Pubitemid 40395999)
26. Wu Z, Podack ER, McKenzie JM, et al. (1994): Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease. Clin Exp Immunol 98: 470-477. (Pubitemid 24374734)
27. Park YW, Kee SJ, Cho YN, et al. (2009): Imparied differentation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum 60: 1753-1763.
28. Thomas HE, Trapani JA, Kay TW (2010): The role of perforin and granzymes in diabetes. Cell Death Differ 17: 577-585.